DAPP1
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide
Also known as: BAM32, DAPP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UN19
- Gene
- DAPP1
- Ensembl
- ENSG00000070190
- Chromosome
- 4
- Canonical length
- 280 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables phosphatidylinositol-3,4,5-trisphosphate binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Predicted to be involved in protein dephosphorylation and signal transduction. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
280 residues, UniProt reviewed canonical sequence.
>Q9UN19|DAPP1
1 MGRAELLEGK MSTQDPSDLW SRSDGEAELL QDLGWYHGNL TRHAAEALLL SNGCDGSYLL
61 RDSNETTGLY SLSVRAKDSV KHFHVEYTGY SFKFGFNEFS SLKDFVKHFA NQPLIGSETG
121 TLMVLKHPYP RKVEEPSIYE SVRVHTAMQT GRTEDDLVPT APSLGTKEGY LTKQGGLVKT
181 WKTRWFTLHR NELKYFKDQM SPEPIRILDL TECSAVQFDY SQERVNCFCL VFPFRTFYLC
241 AKTGVEADEW IKILRWKLSQ IRKQLNQGEG TIRSRSFIFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DAPP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 36 nTPM
- lymph node: 32 nTPM
- esophagus: 24 nTPM
- appendix: 21 nTPM
- spleen: 16 nTPM
- bone marrow: 15 nTPM
Single-cell type
- platelets: 816 nCPM
- esophageal apical cells: 798 nCPM
- urothelial cells: 714 nCPM
- cdc: 285 nCPM
- megakaryocytes: 253 nCPM
- ocular epithelial cells: 253 nCPM
Immune cell
- neutrophil: 138 nTPM
- naive B-cell: 99 nTPM
- memory B-cell: 91 nTPM
- myeloid DC: 76 nTPM
- eosinophil: 71 nTPM
- classical monocyte: 70 nTPM
Brain region
- white matter: 3.5 nTPM
- medulla oblongata: 2.6 nTPM
- pons: 2.4 nTPM
- cerebral cortex: 2.2 nTPM
- spinal cord: 2.2 nTPM
- thalamus: 1.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.17
- gnomAD missense Z
- 1.87
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- phosphatidylinositol-3,4,5-trisphosphate binding
- phosphatidylinositol-3,4-bisphosphate binding
- phospholipid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DAPP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DAPP1 as an antibody target. Whether an autoantibody or antibody against DAPP1 could matter depends on whether native DAPP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DAPP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DAPP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...